ABC
EGRX

Associated Banc-Corp’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Associated Banc-Corp’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-27
Closed -$1K – 910
2020
Q4 		$1K Hold
27
– – ﹤0.01% 956
2020
Q3 		$1K Buy
+27
New +$1.18K ﹤0.01% 951

Other funds holding EGRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Associated Banc-Corp's EGRX Position: Q1 2021 in Review

Associated Banc-Corp sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q1 2021, closing a stake of 27 shares — an estimated $1K sold.

Associated Banc-Corp first reported a position in EGRX in Q3 2020 and held it in 2 quarters. The position peaked at $1K in Q4 2020. 155 funds tracked by Wall St. Rank hold EGRX as of Q1 2021.

  • Associated Banc-Corp reported no remaining Eagle Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 27 Eagle Pharmaceuticals, Inc. shares in Q1 2021, an estimated $1K.
  • Associated Banc-Corp first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2020 and held it in 2 quarters.
  • Associated Banc-Corp's Eagle Pharmaceuticals, Inc. position peaked at $1K in Q4 2020.
  • 155 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.